Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7021043 | 0.94 | CXCR3 (0.62) | CXCR3CYP3A4 | |
| SCHEMBL16209820 | 0.94 | CXCR3 (0.73) | CXCR3CYP3A4 | |
| SCHEMBL18092522 | 0.89 | CXCR3 (0.73) | CXCR3CYP3A4 | |
| SCHEMBL3103736 | 0.83 | CXCR3 (0.60) | CXCR3CYP3A4 | |
| SCHEMBL433439 | 0.83 | CXCR3 (1.00) | CXCR3CYP3A4 | |
| SCHEMBL335753 | 0.83 | CXCR3 (1.00) | CXCR3CYP3A4 | |
| SCHEMBL29386766 | 0.83 | CXCR3 (1.00) | CXCR3CYP3A4 | |
| SCHEMBL12857733 | 0.78 | CXCR3 (1.00) | CXCR3CYP3A4 | |
| SCHEMBL5833103 | 0.78 | CXCR3 (0.89) | CXCR3CYP3A4 | |
| SCHEMBL27015148 | 0.78 | CXCR3 (0.89) | CXCR3CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2755708-A2 | INHALER | Astrazeneca AB (SE) | 2014-07-23 | — | — | EP | disclosed |
| EP-2755707-A1 | INHALER | Astrazeneca AB (SE) | 2014-07-23 | — | — | EP | disclosed |
| EP-2595684-A1 | INHALER | AstraZeneca AB (SE) | 2013-05-29 | — | — | EP | disclosed |
| EP-2595683-A2 | INHALER | AstraZeneca AB (SE) | 2013-05-29 | — | — | EP | disclosed |
| WO-2013038169-A1 | INHALER | ASTRAZENECA AB (SE) | 2013-03-21 | — | — | WO | disclosed |
| WO-2013038170-A2 | INHALER | ASTRAZENECA AB (SE) | 2013-03-21 | — | — | WO | disclosed |
| EP-2534054-A1 | PROCESS FOR PROVIDING A FILLED CANISTER FOR AN INHALER | AstraZeneca UK Limited (GB) | 2012-12-19 | — | — | EP | disclosed |
| WO-2012085582-A1 | COMPOUND | ASTRAZENECA AB (SE) | 2012-06-28 | — | — | WO | disclosed |
| WO-2012085583-A1 | NEW COMPOUND | ASTRAZENECA AB (SE) | 2012-06-28 | — | — | WO | disclosed |
| EP-2448623-A1 | DISPENSER AND METHOD FOR ENTRAINING POWDER IN AN AIRFLOW | AstraZeneca AB (SE) | 2012-05-09 | — | — | EP | disclosed |
| WO-2010042036-A1 | INHALER WITH AUDIBLE INDICATOR MEANS | ASTRAZENECA AB (SE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010042035-A1 | INHALER WITH INDEXING LINKED TO MOVEMENT OF COVER | ASTRAZENECA AB (SE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010042034-A1 | A BREATH ACTIVATED INHALER | ASTRAZENECA AB (SE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010004319-A1 | COMBINATION COMPRISING 6-FLU0R0-N- ((1S, 4S) - 4- (6-FLUORO-2, 4-DI0X0-1- (4'- (PIPERAZIN-1- YLMETHYL) BIPHENYL- 3-YL) -1, 2-DIHYDROPYRIDO [2, 3-D] PYRIMIDIN-3 (4H) - YL) CYCLOHEXYL) IMIDAZO [1,2-A] PYRIDINE -2- CARBOXAMIDE OR A SALT | ASTRAZENECA AB (SE) | 2010-01-14 | — | — | WO | disclosed |
| WO-2009154562-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A 4-HYDROXY-2-OXO-2, 3- DIHYDRO-1, 3-BENZOTHIAZOL-7-YL COMPOUND FOR MODULATION OF BETA2-ADRENORECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2009-12-23 | — | — | WO | disclosed |
| EP-2117542-A1 | COMBINATIONS OF BETA- 2 -ADRENOCEPTOR AGONISTIC BENZOTHIAZOLONE | AstraZeneca AB (SE) | 2009-11-18 | — | — | EP | disclosed |
| WO-2009037503-A2 | NEW COMBINATION - 012 FOR THE TREATMENT OF RESPIRATORY DISEASES | ASTRAZENECA AB (SE) | 2009-03-26 | — | — | WO | disclosed |
| WO-2008104776-A1 | COMBINATIONS OF BETA-2-ADRENOCEPTOR AGONISTIC BENZOTHIAZOLONE | ASTRAZENECA AB (SE) | 2008-09-04 | — | — | WO | disclosed |
| WO-2008096111-A1 | COMBINATIONS OF BETA- 2 -ADRENOCEPTOR AGONISTIC BENZOTHIAZOLONE | ASTRAZENECA AB (SE) | 2008-08-14 | — | — | WO | disclosed |
| WO-2008096121-A1 | COMBINATIONS OF BETA-2-ADRENOCEPTOR AGONISTIC BENZOTHIAZOLONE | ASTRAZENECA AB (SE) | 2008-08-14 | — | — | WO | disclosed |